Gastric Mucosa-associated Lymphoid Tissue Lymphoma: Posttransplant Lymphopoliferative Disorder

Am J Med Sci. 2016 Oct;352(4):439-441. doi: 10.1016/j.amjms.2016.04.011. Epub 2016 Apr 22.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anemia, Aplastic / complications
  • Anemia, Aplastic / therapy
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Cyclophosphamide / administration & dosage
  • Female
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Lymphoma, B-Cell, Marginal Zone / complications
  • Lymphoma, B-Cell, Marginal Zone / diagnosis*
  • Lymphoma, Non-Hodgkin / complications
  • Lymphoma, Non-Hodgkin / diagnosis*
  • Lymphoproliferative Disorders / complications
  • Lymphoproliferative Disorders / diagnosis*
  • Postoperative Complications
  • Prednisone / administration & dosage
  • Rituximab / administration & dosage
  • Stomach Neoplasms / complications
  • Stomach Neoplasms / diagnosis*
  • Vincristine / administration & dosage

Substances

  • Immunosuppressive Agents
  • Rituximab
  • Vincristine
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • COP protocol 2
  • Familial primary gastric lymphoma